Betaserc Side Effects

8444457-8 | Cholestatic Liver Injury, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased
on Jun 07, 2012 Male patient from SWITZERLAND , 84 years of age, was treated with Betaserc(View Usage). Patient experienced the following unwanted or unexpected effects: cholestatic liver injury, gamma-glutamyltransferase increased, blood alkaline phosphatase increased. Betaserc dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMLODIPIN ACTAVIS (View Amlodipin Actavis Review and Amlodipin Actavis Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), NEXIUM (View Nexium Review and Nexium Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), HALDOL (View Haldol Review and Haldol Label ), FERINJECT (View Ferinject Review and Ferinject Label ).

8376388-6 | Transient Ischaemic Attack, Paraesthesia, Skin Odour Abnormal, Loss Of Consciousness, Somnolence, Confusional State, Fatigue, Apathy, Hepatic Cyst
Patient was taking Betaserc (View Usage). Patient had the following side effects: transient ischaemic attack, paraesthesia, skin odour abnormal, loss of consciousness, somnolence, confusional state, fatigue, apathy, hepatic cyst on May 15, 2012 from CROATIA (local name: Hrvatska) Additional patient health information: Female patient , 78 years of age, weighting 163.1 lb, was diagnosed with deafness, diabetes mellitus, endolymphatic hydrops and. Betaserc dosage: . During the same period patient was treated with GLURENORM (1 Df, Qd) (View Glurenorm Review and Glurenorm Label ), HYDROCHLOROTHIAZIDE W/CILAZAPRIL (View Hydrochlorothiazide W/cilazapril Review and Hydrochlorothiazide W/cilazapril Label ), MODURETIC 5 50 (1 Df, Qd) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), BISOPROLOL FUMARATE (1 Df, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

8376018-3 | Convulsion, Sciatica, Headache
Adverse event was reported on May 14, 2012 by a Female patient taking Betaserc (View Usage) (Dosage: 1 Df, A Day) was diagnosed with dizziness (What is dizziness?), insomnia, blood cholesterol increased, convulsion and. Location: BRAZIL , weighting 160.9 lb, After Betaserc was administered, patient had the following side effects: convulsion, sciatica (What is sciatica?), headache (What is headache?). During the same period patient was treated with CLONAZEPAM (0.25 Mg, At Night) (View Clonazepam Review and Clonazepam Label ), SIMVASTATIN (1 Df, At Night) (View Simvastatin Review and Simvastatin Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), TRILEPTAL (2 Df, (1 Tablet In The Morning And 1 Tablet At Night)) (View Trileptal Review and Trileptal Label ).

8133684-5 | Atrioventricular Block Second Degree, Heart Rate Decreased, Sense Of Oppression
on Feb 08, 2012 Female patient from FRANCE , 50 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaserc (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, heart rate decreased, sense of oppression. Betaserc dosage: Unk Ukn, Unk. During the same period patient was treated with DITROPAN (Unk Ukn, Unk) (View Ditropan Review and Ditropan Label ), TROSPIUM CHLORIDE (Unk Ukn, Unk) (View Trospium Chloride Review and Trospium Chloride Label ), GILENYA (0.5 Mg, Daily) (View Gilenya Review and Gilenya Label ), LYRICA (Unk Ukn, Unk) (View Lyrica Review and Lyrica Label ), TANGANIL (Unk Ukn, Unk) (View Tanganil Review and Tanganil Label ). Patient was hospitalized.


7544065-7 | Hypertension, Micturition Frequency Decreased
on Oct 21, 2005 Male patient from BRAZIL , 67 years of age, weighting 172.0 lb, was diagnosed with ear disorder, diabetes mellitus, hypertension, blood cholesterol increased and was treated with Betaserc(View Usage). Patient had the following side effects: hypertension, micturition frequency decreased. Betaserc dosage: 1 Tablet, Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ANCORON (View Ancoron Review and Ancoron Label ), INSULIN (30 Cc) (View Insulin Review and Insulin Label ), DIOVAN (160 Mg, Qd) (View Diovan Review and Diovan Label ), SINVACOR (1 Tablet, Qd) (View Sinvacor Review and Sinvacor Label ). Patient was hospitalized.

7371722-8 | Lower Limb Fracture
Patient was taking Betaserc (View Usage). After Betaserc was administered, patient had the following side effects: lower limb fracture on Mar 15, 2011 from SWITZERLAND Additional patient health information: Female patient , 65 years of age, was diagnosed with meniere's disease (What is meniere's disease?), ophthalmologic treatment, osteoporosis (What is osteoporosis?), gastritis and. Betaserc dosage: . During the same period patient was treated with ACULAR (View Acular Review and Acular Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIMAGON D3 (View Calcimagon D3 Review and Calcimagon D3 Label ), NEXIUM (View Nexium Review and Nexium Label ), VITAMINE A (View Vitamine A Review and Vitamine A Label ), BONIVA (View Boniva Review and Boniva Label ), PROTAGENT (View Protagent Review and Protagent Label ), LACRYCON (View Lacrycon Review and Lacrycon Label ). Patient was hospitalized.

5146959-9 | Vomiting
Adverse event was reported on Oct 25, 2006 by a Male patient taking Betaserc (View Usage) (Dosage: ) was diagnosed with neurological symptom and. Location: , weighting 144.4 lb, Patient experienced the following unwanted or unexpected effects: vomiting. During the same period patient was treated with ZOXON (View Zoxon Review and Zoxon Label ), PENESTER (View Penester Review and Penester Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (400 Mg/m?, Iv Bolus D1+d2 Followed By 5-fu 2400 Mg/m? Over 46-hour Continuous Infusion.) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5143540-2 | Incorrect Dose Administered, Rhabdomyolysis
on Oct 26, 2006 Male patient from SWITZERLAND , 60 years of age, weighting 187.4 lb, was diagnosed with heart transplant (What is heart transplant?), coronary artery disease (What is coronary artery disease?) and was treated with Betaserc (View Usage). Patient had the following side effects: incorrect dose administered, rhabdomyolysis. Betaserc dosage: . During the same period patient was treated with BELOC (View Beloc Review and Beloc Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5142496-6 | Vomiting
on Oct 25, 2006 Male patient from , weighting 144.4 lb, was diagnosed with neurological symptom and was treated with Betaserc(View Usage). After Betaserc was administered, patient had the following side effects: vomiting. Betaserc dosage: . During the same period patient was treated with ZOXON (View Zoxon Review and Zoxon Label ), PENESTER (View Penester Review and Penester Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN (View Leucovorin Review and Leucovorin Label ), FLUOROURACIL (400 Mg/m?, Iv Bolus D1+d2 Followed By 5-fu 2400 Mg/m? Over 46-hour Continuous Infusion.) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.